These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36519732)

  • 1. Lot-to-lot difference: a new approach to evaluate regression studies.
    Lim CY; Markus C; Loh TP
    Scand J Clin Lab Invest; 2023 Feb; 83(1):58-59. PubMed ID: 36519732
    [No Abstract]   [Full Text] [Related]  

  • 2. Lot-to-lot reagent changes and commutability of quality testing materials for total bile acid measurements.
    Markus C; Coat S; Marschall HU; Matthews S; Loh TP; Rankin W; Hague WM
    Clin Chem Lab Med; 2023 Jun; 61(7):e108-e111. PubMed ID: 36639839
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of reagent lot-to-lot comparability tests in five immunoassay items.
    Kim HS; Kang HJ; Whang DH; Lee SG; Park MJ; Park JY; Lee KM
    Ann Clin Lab Sci; 2012; 42(2):165-73. PubMed ID: 22585613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting long-term drift in reagent lots.
    Liu J; Tan CH; Loh TP; Badrick T
    Clin Chem; 2015 Oct; 61(10):1292-8. PubMed ID: 26272234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data.
    Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD
    Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lot-to-lot variation in three thyroid-related radioimmunoassay kits.
    Zweig MH; Robertson EA
    Clin Chem; 1980 Apr; 26(5):646-8. PubMed ID: 7261313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability.
    Bayat H; Johansen JV; Bachmann L; Person N
    Clin Chem Lab Med; 2023 Oct; 61(11):e215-e217. PubMed ID: 37255006
    [No Abstract]   [Full Text] [Related]  

  • 8. Centralization of multisite reagent lot-to-lot validation for Ortho Clinical Vitros chemistry instruments.
    To M; Raizman JE; Goudreau BL; Higgins T; Brun M; Tsui AKY
    Clin Biochem; 2021 Nov; 97():62-66. PubMed ID: 34343576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selecting methods of controls concentration for internal quality control and continuity of control chart between different reagent lots for HBsAg qualitative detection].
    Li JM; Zheng HJ; Wang LN; Deng W
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):228-31. PubMed ID: 12716523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice.
    Cho MC; Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2014 Nov; 51(Pt 6):688-94. PubMed ID: 24497612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commutability limitations influence quality control results with different reagent lots.
    Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE
    Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on lot-to-lot changes.
    Bais R; Chesher D
    Clin Chem; 2014 Feb; 60(2):413-4. PubMed ID: 24115135
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement.
    Chen X; Wang J; Zhang W; Xie E; Zhang B; Xu HG
    J Clin Lab Anal; 2019 Nov; 33(9):e22991. PubMed ID: 31373724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions.
    Algeciras-Schimnich A; Bruns DE; Boyd JC; Bryant SC; La Fortune KA; Grebe SK
    Clin Chem; 2013 Aug; 59(8):1187-94. PubMed ID: 23592508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
    Wener MH; Daum PR; Brawer MK
    Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 17. The Importance of Reagent Lot Registration in External Quality Assurance/Proficiency Testing Schemes.
    Stavelin A; Riksheim BO; Christensen NG; Sandberg S
    Clin Chem; 2016 May; 62(5):708-15. PubMed ID: 26980211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lot-to-lot inconsistency of anticardiolipin reagents.
    Hoefner DM; Yeo KT
    Clin Chem; 2002 Sep; 48(9):1625-6; author reply 1626. PubMed ID: 12194956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of the control serum measurement in infectious disease tests--a case of lot-to-lot variation of anti-HIV antibody assay kit].
    Sasaki M; Sasaki K
    Rinsho Byori; 2002 Jul; 50(7):717-20. PubMed ID: 12187712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total error evaluation of Roche direct HDL-cholesterol reagent and calibrator across 31 lot combinations: a 2-year experience.
    Cobbaert CM; Luderer TK
    Clin Chem; 2000 Jan; 46(1):133-4. PubMed ID: 10620588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.